Stocks › PBYI
PUMA BIOTECHNOLOGY, INC.
PBYI·Nasdaq·
United States·USD
United States·USD$9.81
+0.31 (+3.26%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
PBYI
PUMA BIOTECHNOLOGY, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
PBYIS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of PBYI by members of U.S. Congress · 7 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Donna ShalalaHouse · D · FL |
PBYIPUMA BIOTECHNOLOGY, INC. · Stock |
Sale $1,001 - $15,000 |
Apr 27, 2020 | May 15, 2019 | Filing ↗ |
| Donna ShalalaHouse · D · FL |
PBYIPUMA BIOTECHNOLOGY, INC. · Stock |
Purchase $1,001 - $15,000 |
Apr 27, 2020 | Jan 23, 2019 | Filing ↗ |
 Nick J. RahallHouse · D · WV |
PBYIPUMA BIOTECHNOLOGY, INC. · Stock |
Sale $1,001 - $15,000 |
Oct 13, 2014 | Sep 26, 2014 | Filing ↗ |
| Nick J. RahallHouse · D · WV |
PBYIPUMA BIOTECHNOLOGY, INC. · Stock |
Purchase $1,001 - $15,000 |
Oct 13, 2014 | Sep 10, 2014 | Filing ↗ |
| Nick J. RahallHouse · D · WV |
PBYIPUMA BIOTECHNOLOGY, INC. · Stock |
Purchase $15,001 - $50,000 |
Aug 14, 2014 | Jul 24, 2014 | Filing ↗ |
| Nick J. RahallHouse · D · WV |
PBYIPUMA BIOTECHNOLOGY, INC. · Stock |
Purchase $1,001 - $15,000 |
Aug 14, 2014 | Jul 30, 2014 | Filing ↗ |
| Nick J. RahallHouse · D · WV |
PBYIPUMA BIOTECHNOLOGY, INC. · Stock |
Sale $15,001 - $50,000 |
Aug 14, 2014 | Jul 23, 2014 | Filing ↗ |
Whale Activity
Position changes in PBYI reported for 2026-06-30 by 8 tracked institutional filers
- Increased4
- New0
- Held0
- Decreased3
- Closed1
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 3.8M | $30.9M | increased |
| RENAISSANCE TECHNOLOGIES LLC | 1.8M | $14.9M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $14.9M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.8M | $14.8M | increased |
| MILLENNIUM MANAGEMENT LLC | 602.2K | $4.9M | decreased |
| D. E. Shaw & Co., Inc. | 316.3K | $2.6M | decreased |
| TWO SIGMA INVESTMENTS, LP | 140.6K | $1.1M | increased |
| Citadel Advisors LLC | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by PBYI insiders, by quarter · Form 4
Recent Insider Transactions
448 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| WILSON TROY EDWARDDirector · Director | Sale | −5,000 | $9.10 | $46K | Sep 14, 2026 | Form 4 ↗ |
| Cesano AlessandraDirector · Director | Sale | −62.1K | $9.12 | $567K | Sep 14, 2026 | Form 4 ↗ |
| AUERBACH ALAN HPresident and CEO · Director | Sale | −44.1K | $8.26 | $364K | Jul 6, 2026 | Form 4 ↗ |
| HUNT DOUGLAS MSee Remarks | Sale | −8,460 | $8.26 | $70K | Jul 6, 2026 | Form 4 ↗ |
| NOUGUES MAXIMO FChief Financial Officer | Sale | −9,386 | $8.26 | $78K | Jul 6, 2026 | Form 4 ↗ |
| WILSON TROY EDWARDDirector | Sale | −10.8K | $7.20 | $78K | Jun 12, 2026 | Form 4 ↗ |
| Stuglik Brian MDirector | Sale | −8,100 | $7.20 | $58K | Jun 12, 2026 | Form 4 ↗ |
| Senderowicz AdrianDirector | Sale | −27.0K | $7.20 | $194K | Jun 12, 2026 | Form 4 ↗ |
| MOYES JAY MDirector | Sale | −22.0K | $7.22 | $159K | Jun 12, 2026 | Form 4 ↗ |
| Dorval AllisonDirector | Sale | −11.6K | $7.20 | $84K | Jun 12, 2026 | Form 4 ↗ |
| WILSON TROY EDWARDDirector | Grant / award | +27.0K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| Stuglik Brian MDirector | Grant / award | +27.0K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| Senderowicz AdrianDirector | Grant / award | +27.0K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| MILLER MICHAEL PATRICKDirector | Grant / award | +27.0K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| MOYES JAY MDirector | Grant / award | +27.0K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| Dorval AllisonDirector | Grant / award | +27.0K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| Cesano AlessandraDirector | Grant / award | +27.0K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| AUERBACH ALAN HPresident and CEO · Director · 10% owner | Grant / award | +159.8K | $0.00 | $0 | Feb 18, 2026 | Form 4 ↗ |
| HUNT DOUGLAS MSee Remarks | Grant / award | +49.4K | $0.00 | $0 | Feb 18, 2026 | Form 4 ↗ |
| NOUGUES MAXIMO FChief Financial Officer | Grant / award | +46.7K | $0.00 | $0 | Feb 18, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding PBYI · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Avantis U.S. Small Cap Value ETF American Century ETF Trust | 1.9M | $13.8M | 0.05% | May 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.3M | $10.9M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.2M | $9.5M | 0.01% | Jun 30, 2026 |
| VANGUARD EXPLORER FUND | 777.4K | $6.2M | 0.03% | Jul 31, 2026 |
| VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS | 540.4K | $4.4M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 484.0K | $3.8M | 0.01% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 437.7K | $3.6M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF iShares Trust | 336.3K | $2.7M | 0.02% | Jun 30, 2026 |
| Small Cap Value Fund Northern Funds | 267.9K | $2.2M | 0.32% | Jun 30, 2026 |
| Small-Cap Value Fund Bridgeway Funds, Inc. | 249.2K | $2.0M | 0.59% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list PBYI's shares (CUSIP 74587V107), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Alan H. AuerbachSCHEDULE 13D/A · activist (13D) · 8.6M shares16.0%
Oct 6, 2026 · ↗ - Acorn Capital Advisors GP 2, LLCSCHEDULE 13G/A · passive (13G) · 1.9M shares3.9%
Nov 14, 2024 · ↗ - Anders HoveSCHEDULE 13G/A · passive (13G) · 3.3M shares6.7%
Nov 14, 2024 · ↗ - ACORN CAPITAL ADVISORS GP, LLCSCHEDULE 13G/A · passive (13G) · 1.4M shares2.8%
Nov 14, 2024 · ↗ - ACORN BIOVENTURES 2, L.P.SCHEDULE 13G/A · passive (13G) · 1.9M shares3.9%
Nov 14, 2024 · ↗ - ACORN BIOVENTURES, L.P.SCHEDULE 13G/A · passive (13G) · 1.4M shares2.8%
Nov 14, 2024 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming PUMA BIOTECHNOLOGY, INC. as client
No lobbying filings found naming PUMA BIOTECHNOLOGY, INC. as the client.
Government Contracts
Federal awards to PUMA BIOTECHNOLOGY, INC. · USAspending
No federal contract awards found for PUMA BIOTECHNOLOGY, INC..
U.S. Patents
Recent USPTO applications naming PUMA BIOTECHNOLOGY, INC.
No USPTO patent applications found for PUMA BIOTECHNOLOGY, INC..
Annual Financials
From PBYI's 10-K filings · XBRL
No annual XBRL figures on record for PBYI. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in PBYI's price history.
About PUMA BIOTECHNOLOGY, INC.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersLOS ANGELES, CA
IncorporatedDE
SEC CIK0001401667 ↗
Former namesINNOVATIVE ACQUISITIONS CORP